Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months

HIV Medicine

Volumn 11, Issue 7, 2010, Pages 457-461

  Engsig, F N ^a   Omland, L H ^a   Larsen, M V ^b   Rasmussen, L D ^c   Qvist, T ^a   Gerstoft, J ^a   Obel, N ^a  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cohort study; Highly active antiretroviral therapy; HIV; Infectiousness; Viraemia; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DRUG USE; FEMALE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEXUAL TRANSMISSION; TREATMENT DURATION; TREATMENT OUTCOME; VIREMIA; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DENMARK; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; POPULATION SURVEILLANCE; RISK ASSESSMENT; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS; TREATMENT FAILURE; VIRAL LOAD; VIREMIA;

EID: 77955125518     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00813.x     Document Type: Article

References (12)

1. Quinn TC, Wawer MJ, Sewankambo N. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000, 342:921-929.
2. Melo M, Varella I, Nielsen K, Turella L, Santos B. Demographic characteristics, sexual transmission and CD4 progression among heterosexual HIV-1 serodiscordant couples followed in Porto Alegre, Brazil. Toronto, ON, Canada, August 2006 [Abstract TUPE0430].
3. Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bull Méd Suisses 2008, 89:165-169.
4. Garnett GP, Gazzard B. Risk of HIV transmission in discordant couples. Lancet 2008, 372:270-271.
5. Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV transmission under highly active antiretroviral therapy. Lancet 2008, 372:1806-1807.
6. http://www.statbank.dk, Statistics Denmark, Population and elections. Available at, (accessed 1 April 2009).
7. Lohse N, Hansen AB, Jensen-Fangel S. Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis 2005, 37:338-343.
8. Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sorensen HT. Cohort profile: The Danish HIV Cohort Study. Int J Epidemiol 2009, 38:1202-1206.
9. Lohse N, Obel N, Kronborg G. Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals. AIDS 2005, 19:815-822.
10. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008, 372:314-320.
11. Ammassari A, Trotta MP, Murri R. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr 2002, 31((Suppl 3)):S123-S127.
12. Smith CJ, Phillips AN, Dauer B. Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppression. HIV Med 2009, 10:19-27.